Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
4.350
+0.200 (4.82%)
Jun 11, 2025, 4:00 PM - Market closed

Company Description

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

It offers microwave ablation apparatus and needles, as well as microwave ablation apparatus approved for the treatment of live cancer and thyroid nodules, long microwave ablation needles, and fine microwave ablation needles through third-party distributors.

Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings logo
Country China
Founded 2012
Industry Medical Devices
Sector Healthcare
Employees 143
CEO Haimei Wu

Contact Details

Address:
Room 202, 2/F, Baide Building
Guangzhou, 510000
China
Phone 86 20 8218 5926
Website bairdmed.com

Stock Details

Ticker Symbol BDMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001982444
CUSIP Number G0705H103
ISIN Number KYG0705H1039
SIC Code 3841

Key Executives

Name Position
Haimei Wu Chairwoman of the Board of Directors and Chief Executive Officer
Quan Qiu Chief Administrative Officer and Executive Director
Wei Hou Executive Director
Jie Li Acting Chief Financial Officer
Rongjian Lu Chief Technology Officer and Deputy GM

Latest SEC Filings

Date Type Title
May 15, 2025 20-F Annual and transition report of foreign private issuers
Apr 30, 2025 NT 20-F Notification of inability to timely file Form 20-F
Jan 28, 2025 6-K Report of foreign issuer
Jan 17, 2025 F-1/A [Amend] Registration statement for certain foreign private issuers
Jan 10, 2025 S-8 Securities to be offered to employees in employee benefit plans
Nov 15, 2024 F-1 Registration statement for certain foreign private issuers
Nov 1, 2024 6-K Report of foreign issuer
Oct 9, 2024 20FR12B Filing
Oct 2, 2024 CERT Certification by an exchange approving securities for listing
Oct 2, 2024 6-K Report of foreign issuer